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Abstract
Objective: The objective of this study was to evaluate the effects of intraoperative epidural anesthesia
combined with balanced general anesthesia on intraoperative hemodynamics and fluid requirement, and
on postoperative patient outcome.
Design: The study design was a retrospective data analysis of patients undergoing open hepatectomy
at a single tertiary care center from May, 2013 to June, 2016. Patients undergoing hepatectomies were
separated into two groups: patients not receiving epidural local anesthetic intraoperatively (either no
epidural or epidural catheter not used intraoperatively) were designated the control group and patients
receiving epidural local anesthetic intraoperatively (bolus and/or continuously). Patients were excluded if
they underwent laparoscopic or non-elective procedures.
Results: 103 patients were included in the data analysis: Control n=14, Epidural = 89 patients. There
were no major differences in demographics between groups. Epidural patients did not have higher
requirements in intraoperative intravenous fluid administration, blood loss, or vasopressor use compared
to control patients. Patients who received epidurals required less intravenous opioids with better postoperative pain scores initially and also on post-operative day 2. There were no differences in length of time
to ambulation, or post-operative acute kidney injury amongst groups.
Conclusions: This study shows that patients undergoing hepatectomies using combined epidural
and general anesthesia: 1) have no increased requirement for intraoperative crystalloid, colloid, or blood
component therapy, 2) require lower total intravenous opioid dose, and 3) subjectively report better
pain control. Therefore, intraoperative epidural anesthesia combined with general anesthesia may be
advantageous for ERAS protocol based oncological procedures.

Introduction
Enhanced Recovery after Surgery (ERAS) protocols are becoming more frequently
used for several surgical procedures after they were irst described by colorectal
surgeons in the 1990’s. The goal of ERAS protocols is to facilitate the early return of
patients to normal physiology by minimizing perioperative stressors [1]. In the ield
of liver surgery randomized clinical trials have proven that ERAS protocols lead to
reduced post-operative complications [1].
Epidural anesthesia has been successfully implemented as part of a multimodal
approach to pain control in patients undergoing ERAS protocols. Epidural usages
HTTPS://WWW.HEIGHPUBS.ORG
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can provide high quality analgesia while also leading to decreased cardiopulmonary
complications, reduced ileus and early mobilization of patients following liver resection
[1-3]. However epidural placement and usage is not without complications. This includes
sympathectomy induced hypotension, spinal headache, epidural hematomas, epidural
abscess or spinal cord injury [3]. Post-operative coagulopathy is expected after liver
surgery due a combination of the extent of liver resection, consumptive coagulopathy,
and blood loss. The degree of post-operative coagulopathy can be related to preoperative
liver synthetic function. Thus, this transient post-operative coagulopathy is typically
maximally deranged on postoperative days one and two and typically resolves on
its own within ive to seven days [3,4]. Therefore, there may be some hesitation by
anesthesia providers to use epidural analgesia perioperatively for this procedure. While
the coagulopathy may pose an increased risk of epidural hematoma formation patients
undergoing hepatectomy and should be monitored prior to epidural catheter removal, it
does not prohibit the placement and usage of epidural analgesia [3,4].
Surgical resection is mainstay for a majority of cancer treatment even though
excision of the primary tumor can result in further dissemination and growth. Stress
from both a surgical and anesthetic point of view has been shown to suppress the
immune system [5]. Pain is an obvious inducer of the stress response thus medication
to reduce pain and in lammation such as opioids and non-steroidal anti-in lammatories
(NSAIDs) can decrease metastatic potential in animal models and humans. Regional
anesthesia can dramatically reduce many of these stress response effects of surgery
and anesthesia. Studies have shown that patients undergoing abdominal surgery with
epidural analgesia had higher numbers of lymphocytes, T-helper cells, preserved
interferon-γ concentrations and a bene icial Helper T cell ratio [5].
Thus, the practice of using epidural analgesia to decrease pain and in lammation
as well as opioid sparing with local anesthesia may play an important role on immune
function and cancer recurrence. However, aggressive use of epidural anesthesia in
combination with general anesthesia during hepatectomy may have signi icant impact
on hemodynamics and intravenous luid requirements.
The primary aim of this study was to investigate if the intraoperative use of
epidural anesthesia and analgesia combined with general anesthesia is associated
with increased use of vasoactive medications or need for more intravenous luid
administration. In addition, the study explored if the epidural use was related to
differences in postoperative analgesia or opioid consumption. We hypothesized that
epidural anesthesia can be safely used intraoperatively during open hepatectomy and
does not interfere with the goals of ERAS protocols for this procedure.

Material and Methods
After approval from the University of Kentucky Institutional Review Board, a
retrospective data analysis was performed on patients undergoing elective open
hepatectomy from May, 2013 to June, 2016. The patient collective was separated into
two groups: patients not receiving epidural local anesthetic intraoperatively (either
no epidural or epidural catheter not used intraoperatively) were designated the
control group [C] and patients receiving epidural local anesthetic intraoperatively [E].
Inclusion criteria into the study was de ined as patients undergoing open procedures
for removal of either primary liver tumors or with metastases to liver. After excluding
patients that underwent laparoscopic procedures, patients with history of liver
transplantation or non-elective procedures, we enrolled fourteen control patients and
eighty-nine epidural patients. We did not take into account if the patient had cirrhosis
or make a distinction between a major or minor hepatectomy in this study.
Due to the small number of control patients compared to those with an epidural, we
identi ied a subgroup of patients in the Epidural group, in which epidural anesthesia
was provided as continuous infusion of local anesthetic (lidocaine 1% or bupivacaine
0.125%) intraoperatively as adjunct to general anesthesia (E gtt, n=23). To further
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quantify the association of epidural use and vasopressor requirements, we performed
a subgroup analysis (Control [C] n=14, Epidural bolus use [E bolus, n=66], and
Epidural continuous infusion [E gtt, n=23]. The main difference between E bolus and
E gtt was that the majority of patients in the E bolus group did not receive epidural
local anesthetics until the inal stage of the surgical procedure. The frequency of
intraoperative vasoconstrictive medication administration for all groups was recorded.
Data collection was performed in a blinded fashion by a clinical support staff
member that was not involved in the analysis of the data before patients were
separated in respective groups. Intraoperative data were collected and analyzed for
opioid use with all opioids converted to fentanyl equivalents via the Global RPh opioid
equivalence calculator [6] and tallied together in Microsoft Excel to determine total
dose, frequency of hypotension de ined as a mean arterial pressure (MAP) less than
60mmHg for >10min duration post incision. Vasopressor therapy was de ined as either
no usage, low dose: less than 500 micrograms (mcg) Phenylephrine, 25 milligrams
(mg) ephedrine, or 2 units of vasopressin accumulatively for the procedure, or high
dose: any vasopressor infusion, any bolus of epinephrine, any combination of drugs
where one drug is a greater than any low parameter.
To investigate the intraoperative implications of continuous epidural anesthesia for
intraoperative management during hepatectomy, we reviewed the anesthesia records
of patient without epidural use [C] and continuous epidural anesthesia [EPI gtt] and
calculated the intraoperative doses of vasoconstrictive medications.
Average total luid administration including blood transfusion, and estimated blood
loss were other intraoperative factors compared between the control and epidural
groups. We also recorded the total amount of opioid for the case after converting all
drugs and routes to intravenous fentanyl equivalents.
Post-operative data were analyzed for pain scores immediately post op, twentyfour and forty-eight hours postoperatively, length of stay, time to ambulation and rate
of acute kidney injury. Data are presented as mean ± standard deviation. Statistical
analysis was performed using a paired T-test and Fisher’s Exact test. Statistical
signi icance was assumed if P value was less than 0.05.

Results
Eighty-nine of the one hundred and three patients met our inclusion criteria and
there were no signi icant demographic differences between the two groups: age (p =
0.35), American Society of Anesthesia Class (p = 0.22), male to female ratio (p = 0.09)
and operating room duration (p = 0.25) (Table 1). Intraoperative epidural use was not
associated with differences in estimated blood loss (p = 0.33), packed red blood cell
transfusion (p = 0.27), total luid administration (crystalloid and colloids) (p = 0.5),
total intravenous crystalloid luid (p = 0.45), and intravenous albumin administration
(p = 0.98). Measured urine output for the case was also compared between the two
groups and was found to have no signi icant difference as well (p = 0.51) (Table 2).
There were no differences in the requirements and extent of vasopressor therapy
between the two cohorts. There was no signi icant difference in the no vasopressor
requirement (E: 33 out of 89 patients, C: 8 out of 14 patients; p = 0.27), low vasopressor
requirements (E: 23 out of 89 patients, C: 1 out of 14 patients; p = 0.31), and high
vasopressor requirement (E: 33 out of 89 patients, C: 5 out of 14 patients; p = 0.62)
factions between the control and epidural cohorts (Figure 1).
Table 1: Demographics of the study population by method of pain control. Data presented as mean ± SD.
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Epidural

Control

N

89

14

p-value

Age (years)

54.2 ± 12.7

50.7 ± 10.1

0.35

ASA class

2.9 ± 0.5

3.0 ± 0.4

0.22

M:F ratio

42:47

10:4

0.09

OR duration (min)

269 ± 91

286 ± 113

0.25
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Table 2: Effects of epidural usage on intraoperative fluid requirements and urine output compared to control. Data
presented as mean ± SD.
N

Epidural

Control

89

14

p-value

EBL (mL)

292 ± 307

455 ± 585

Total Fluids (mL)

2301± 1236

2757 ± 2436

0.33
0.5

IVF Crystalloid (mL)

1975 ± 1020

2436 ± 2166

0.45
0.98

IVF Albumin 5% (mL)

325 ± 400

321 ± 504

PRBC transfusion (units)

0.03 ± 0.3

0.5 ± 1.3

0.27

UOP (mL)

208 ± 172

356 ± 418

0.51

Figure 1: Effects of epidural usage on intraoperative vasopressor frequency and magnitude.
The frequency of vasopressor use was compared in the following groups: patients receiving epidural anesthesia
combined with general anesthesia intraoperatively [Epidural, n=89], were compared to patients without epidural
anesthesia or not used intraoperatively [Control, n=14].
Vasopressors were quantified as no usage, Low = < 500mcg Phenylephrine, < 25mg ephedrine, < 2 units of
vasopressin for the case. High = any vasopressor infusion, any bolus of epinephrine or any combination of drugs
where one drug is a greater than any low parameter. Data presented as fraction from total.

To obtained more detailed information about vasopressor use and association
with intraoperative epidural anesthesia, we identi ied a subgroup of patients in the
Epidural group, in which epidural anesthesia was provided as continuous infusion of
local anesthetic (lidocaine 1% or bupivacaine 0.125%) intraoperatively as adjunct
to general anesthesia (E gtt, n=23). The frequency of intraoperative vasoconstrictive
medication administration is shown in table 3. The frequency of vasoconstrictive
medications was not signi icantly different between Control group and epidural
bolus use. There was no difference in low vasopressor requirements between Control
patients and patients receiving continuous epidural anesthesia intraoperatively.
For further analysis of intraoperative vasoconstrictive medication administration,
we calculated the intraoperative doses of vasoconstrictive medications given to
patients in the Control group and to patients with continuous epidural anesthesia
(Table 4). The most commonly given agent was phenylephrine. The phenylephrine
dose was not different between the groups. The other agents (ephedrine, vasopressin
and norepinephrine) were given less frequently and less consistently, most likely
representing the preferences of the anesthesia provider. While the data indicated a
signi icantly larger dose of ephedrine in patients with continuous epidural anesthesia,
the other, more potent vasoactive medications (Vasopressin and Norepinephrine)
were used in both groups in similar concentrations.
In addition to vasopressor use, the subanalysis did not show any differences in
intravenous luid administration between the control group and patients receiving
continuous intraoperative epidural anesthesia. In average, patient in the control group
received 2757 ± 2436ml intravenous luids (crystalloid 2436 ± 2169ml, albumin 5%
Published: November 13, 2018
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321 ± 504ml). The average for patient with intraoperative continuous epidural local
anesthesia infusion [E gtt] was 2244 ± 1330ml (crystalloid 1859 ± 1077ml, albumin
5% 385 ± 395ml).
When comparing opioid requirements between the control and epidural group,
the epidural cohort required signi icantly less intravenously bolused opioids 286 ±
251mcg in the epidural group versus 629 ± 568 mcg in the control group (p = 0.04).
However, when comparing the total dose of opioids for the case 426 ± 251 mcg in the
epidural group versus 629 ± 568 mcg in the control group this was not signi icantly
different (p = 0.21) (Figure 2).
Post operatively, pain scores were assessed via the Visual Analog Scale (VAS)
initially after surgery, post-operative day one (24hrs postop) and post operatively day
two (48hrs postop). There was a signi icant difference in VAS pain scores at the initial
assessment 5.4 ± 3.5 in the epidural cohort versus 8.25 ± 2.0 in the control (p < 0.01).
This was shown as well on post-operative day two 4.2 ± 2.8 in the epidural cohort and
6.8 ± 1.5 in the control cohort (p < 0.01). However, pain scores on postoperative day
one were not signi icantly different between the two cohorts (p = 0.06) (Figure 3). The
rate of acute kidney injury (p = 0.64), time to ambulation (p = 0.11), time to eating (p =
0.25), time to irst bowel movement (p = 0.25), and time to discharge (p = 0.46) were
not different between the two cohorts (Table 5).
Table 3: Frequency of intraoperative vasoconstrictive medication administration.
Control: no epidural anesthesia, E bolus: bolus epidural local anesthetics, E gtt: continuous intraoperative epidural local
anesthetic infusion.
Statistical analysis with Fisher exact test (p=values), * p<0.05.
Control

E bolus

E gtt

14

66

23

N

P value
C vs E bolus

P value
C vs E gtt

No vasopressor use

8

28

5

0.14

0.03

Low vasopressor use

1

16

7

0.24

0.07

High vasopressor use

5

22

11

0.76
high vs low
0.38

0.14
high vs low
0.62

Table 4: IntraoperativeVasopressor doses for selected subgroups.
Control: no epidural anesthesia, E gtt: continuous intraoperative epidural local anesthetic infusion.
Data are presented as mean ± SD. Statistical analysis with paired t-test * p<0.05.
N

Control

E gtt

14

23

P value

Phenylephrine

[mcg]

1064.1 ± 3681.7

635.6 ± 1230.4

0.61

Ephedrine

[mg]

1.43 ± 5.35

12.83 ± 19.47*

0.04

Vasopressin

[Units]

1.37 ± 3.08

1.05 ± 2.91

0.75

Norepinephrine

[mcg]

29.57 ± 110.65

4.66 ± 22.36

0.30

900

*
800

Fentanyl [mcg]

700
600
500
400
300
200
100
0
Opioid in IV Bolus Form

Cumulative Opioid Dose
Epidural

Control

Figure 2: Comparison of the effect of epidural usage and intraoperative opioid requirements in IV bolus form and
case total opioids. All opioids have been converted in to intravenous fentanyl equivalents [6].
Data presented as mean ± SEM. * = p < 0.05.
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10

*

*

9
8

VAS Score

7
6
5
4
3
2
1
0
Initial Pain Score

POD 1 Max
Epidural

POD 2 Max

Control

Figure 3: Effects of epidural usage on VAS scores on the initial post-operative assessment, and maximum pain
scores on post-operative day 1 and 2. Data presented as mean ± SEM. * = p < 0.05

Table 5: Comparison of post-operative outcomes in patients that received epidural analgesia versus control. Data
presented as mean ± SD.
N

Epidural

Control

89

14

p-value

AKI (percent of patients)

8.9%

7.1%

0.64

Time to ambulation (days)

2.1 ± 1.3

2.9 ± 1.6

0.11

Time to eating (days)

3.6 ± 1.8

4.9 ± 4.0

0.25

Time to return of bowel function (hours)

87 ± 24

97 ± 35

0.21

Time to discharge (days)

6.9 ± 3.3

7.7 ± 3.6

0.46

The selection of pain control method was not standardized for the patient population
and was determined by the surgeon and attending anesthesiologist. Postoperative pain
control for rescue was again not standardized as this was at the discretion of the acute
pain attending anesthesiologist. Rescue maneuvers that occurred would have included
titration of the epidural infusion with continued patient-controlled boluses, addition
of intravenous patient-controlled analgesia after removal of the opioid component in
the epidural infusion, removal of the epidural catheter if deemed non-functional and
utilization of intravenous or oral opioid medications. In the control group post-operative
analgesia outside of the post-operative care unit was at the discretion of the attending
surgical oncologist. There was no reported epidural hematoma or abscess formation
after epidural placement or removal, however there is no data on any delays in catheter
removal secondary to coagulopathy.

Discussion
Epidural usage during abdominal surgeries provides excellent analgesia with reduced
cardiopulmonary complications, duration of ileus and opioid requirements however,
there is concern over complications associated with their usage and placement [3,7].
Liver surgery itself places patients at an increased risk of post-operative coagulopathy
and development of epidural hematoma following catheter removal [3,4]. Other
complications of intraoperative epidural usage in ERAS patients are sympathectomy
induced hypotension with concomitant additional luid requirements and possibly red
cell transfusion [1-3].
Our study found that the intraoperative use of epidural anesthesia and analgesia with
local anesthetics and opioids in addition to general anesthesia during hepatectomy is
not associated with an increased vasopressor use or intravenous luid administration.
The study con irmed that intraoperative epidural use is safe and that the provided
analgesia may be superior to intravenous opioid based analgesia, and may offer
additional opioid-sparing advantages for patients undergoing oncological resections.
Published: November 13, 2018
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Epidural induced sympathectomy and concomitant hypotension can lead to
increased luid and vasopressor requirements as a response to the relative hypovolemia.
This is a concern in patients undergoing major abdominal surgery with ERAS protocols
[1-3]. Our study showed no statistically signi icant increase in luid requirements, blood
product transfusion or vasopressor usage. Speci ically, our study documented that
the continuous epidural local anesthesia infusions as an adjunct to balanced general
anesthesia did not increase intravenous luid administration or changed vasopressor
requirements, therefore supporting the goals of the ERAS approach. These results
are a favorable hemodynamic pro ile with epidural usage in comparison to the recent
literature. Allen et al. [2], showed no signi icant difference in luid requirements
between their cohort comparing epidural and IVPCA patients undergoing liver
resection. However, Siniscalchi et al. [4], found that epidural anesthesia increased
the use of intravenous colloid administration. However, they did not ind a difference
in crystalloid or red cell transfusion. Recorded urine output in this study showed no
signi icant difference between epidural and control patients, this is similar in result
to the Siniscalchi et al. [1]. To our knowledge, this is the irst study documenting that
epidural anesthesia in combination with general anesthesia is not associated with
an increased use in vasoconstrictive or inotrope medications during hepatectomy to
maintain normotension. While Siniscalchi et al. [1] reported an association of epidural
anesthesia with lower MAP post liver resection and at the end of surgery, the authors
did not report intraoperative treatment and signi icance of the hypotension.
This study data indicates that epidural usage intraoperatively leads to decreased
bolus IV opioids, however total dose of opioid was not statistically signi icant. Usage
of epidural catheters with local anesthetic and opioid may typically results in opioid
sparing effects. This may be bene icial due to studies showing that opioids themselves
can result in tumor progression via endothelial cell proliferation and angiogenesis5.
Non-small cell lung carcinomas for example have been shown to express the muopioid receptor at ive to ten-fold higher levels than normal cells. Morphine has been
the most studied opioid in this context and has been shown to stimulate endothelial
cell proliferation, inhibition endothelial apoptosis resulting in angiogenesis and tumor
progression in rat models. However, opioids themselves assist in blocking the stress
response which may lead to a favorable immunologic pro ile in the patient possibly
leading to decreased metastasis. This is due in part to pro-in lammatory cytokines
decreasing T-cell, B-cell and natural killer (NK) cell function for days following a
surgical insult. NK cells play an important role in tumor biology since their activity
can be correlated to patient’s susceptibility to multiple types of cancers. Studies
have shown that decreased NK cell activity from stress induced cytokines results in
increased metastasis and when those stress cytokines are blocked we see the reverse
effect5. This makes a case for further study into long term cancer recurrence in patients
undergoing hepatectomies with opioid sparing techniques. However, the data about
immunomodulation has been only shown in rat models and no long-term translation
studies in humans have been conducted thus far.
In regards to routes of administration when given systemically opioids act on
all corresponding receptors throughout the body. Studies have shown that there is
synergy between spinal and systemic administration where small doses of spinal
morphine signi icantly potentiated the activity of systemic morphine [8]. In clinical
practice, epidural administration of opioids leads to higher concentrations of the drug
at the spinal level secondary to their diffusion into the cerebrospinal luid. Also the
epidurally administered opioid is absorbed into the systemic circulation via the highly
vascular Batson’s venous plexus [9]. This could explain the decreased requirements
for bolus IV opioid in our epidural group.
Post-operative outcomes were also assessed and patients that received epidurals
had superior pain control immediately post-op as well as at 48 hours based off VAS
Published: November 13, 2018
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scores. It was also noted that when comparing the two groups there was no difference
in the rate of AKI post op as well. However, other post-operative outcomes such as
length of stay and time to eating, return of bowel function, ambulation did not show
any signi icant difference. This is an agreement with the Allen et al. [2] study who also
was unable to show differences in length of stay or time to eating and Siniscalchi et al.
[1], who compared creatinine at post-op days 1, 3 and 7.
Potential limitations of this study are its retrospective nature and the possible addition
of selection and/or information biases. We were reliant upon the documentation in the
medical record as accurate and precise with proper standardization. However, there is
the opportunity for the variable to either be missing, delayed or incomplete. There was
also no standardized anesthetic plan for patients undergoing elective hepatectomies and
thus some patients received other medications both preoperative and intraoperatively
which may have an effect on the results of this study. The patient cohorts were at a single
university hospital and thus unable to compare patients undergoing the same procedure in
other areas of the country. We also are unable to evaluate the long-term impact on patient
morbidity and mortality to evaluate for long term outcomes of opioid sparing techniques.
This study shows that patients undergoing hepatectomies using combined epidural and
general anesthesia had no increased intraoperative requirements for intravenous luid and
vasopressor usage and required a lower total intravenous opioid dose perioperatively for
adequate pain control. When comparing postoperative outcomes, patients with epidurals
had better pain control without a difference in post-operative complications. Although
we did not ind differences in length of stay, time to ambulation, or time to tolerating oral
intake, future studies are needed to explore any advantages of opioid sparing anesthesia
techniques for patients undergoing hepatectomy. Thus, with the advent of ERAS protocols
and fast track liver surgery combined epidural and general anesthesia is safe and possibly
more bene icial outcomes given the decreased IV opioid requirements.
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